Addex Therapeutics Statistics

Total Valuation

FRA:APE has a market cap or net worth of EUR 6.23 million. The enterprise value is 3.25 million.

Market Cap	6.23M
Enterprise Value	3.25M

Important Dates

The next estimated earnings date is Monday, September 1, 2025.

Earnings Date	Sep 1, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	98.35M
Shares Outstanding	n/a
Shares Change (YoY)	+17.91%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	26.11M

Valuation Ratios

The trailing PE ratio is 0.69.

PE Ratio	0.69
Forward PE	n/a
PS Ratio	24.18
PB Ratio	0.72
P/TBV Ratio	0.72
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	0.36
EV / Sales	12.34
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.82

Financial Position

The company has a current ratio of 3.03, with a Debt / Equity ratio of 0.00.

Current Ratio	3.03
Quick Ratio	2.71
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.01
Interest Coverage	-738.55

Financial Efficiency

Return on equity (ROE) is -163.15% and return on invested capital (ROIC) is -45.97%.

Return on Equity (ROE)	-163.15%
Return on Assets (ROA)	-25.09%
Return on Invested Capital (ROIC)	-45.97%
Return on Capital Employed (ROCE)	-30.53%
Revenue Per Employee	128,838
Profits Per Employee	4.54M
Employee Count	2
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -95.58% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-95.58%
50-Day Moving Average	0.19
200-Day Moving Average	1.07
Relative Strength Index (RSI)	24.23
Average Volume (20 Days)	48

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:APE had revenue of EUR 257,675 and earned 9.07 million in profits. Earnings per share was 0.09.

Revenue	257,675
Gross Profit	-543,281
Operating Income	-2.69M
Pretax Income	-5.91M
Net Income	9.07M
EBITDA	-2.49M
EBIT	-2.69M
Earnings Per Share (EPS)	0.09

Full Income Statement

Balance Sheet

The company has 2.96 million in cash and 42,078 in debt, giving a net cash position of 2.92 million.

Cash & Cash Equivalents	2.96M
Total Debt	42,078
Net Cash	2.92M
Net Cash Per Share	n/a
Equity (Book Value)	8.68M
Book Value Per Share	0.09
Working Capital	2.24M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -3.95 million and capital expenditures -1,332, giving a free cash flow of -3.96 million.

Operating Cash Flow	-3.95M
Capital Expenditures	-1,332
Free Cash Flow	-3.96M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is -210.84%, with operating and profit margins of -1,045.31% and 3,521.74%.

Gross Margin	-210.84%
Operating Margin	-1,045.31%
Pretax Margin	-2,293.80%
Profit Margin	3,521.74%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FRA:APE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-17.91%
Shareholder Yield	n/a
Earnings Yield	145.66%
FCF Yield	-63.49%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:APE has an Altman Z-Score of -49.11 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-49.11
Piotroski F-Score	2